Furthermore, the prevalence of moderate or severe anemia was higher in the PCH cohorts during both the pre-COVID phase (13/55 [31%] versus 19/136 [14%]; OR = 1.90; p = 0.13) and the SARS-CoV-2 + phase (63/102 [62%] versus 77/272 [28%]; OR = 4.07; p = 4.99 × 10 −9 ), although the former observation did not reach statistical significance ( Figures 5 D and 5E).
← all excerpts
Anemia during SARS-CoV-2 infection is associated with rehospitalization after viral clearance.
1
—
—